Inclusion of Strep-tag II in design of antigen receptors for T-cell
immunotherapy. Nature Biotechnology (2016)
doi:10.1038/nbt.3461
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4
+ subsets confer superior antitumor reactivity in vivo. Leukemia (15
September 2015) | doi:10.1038/leu.2015.247
THanks,